Related Experiment Video
Updated: Dec 9, 2025

06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
9.8K
Different TERT Expression between Colorectal Adenoma and Serrated Polyp.
Soo-Jung Jung1, Jae-Hee Park1, Ilseon Hwang2
1Department of Anatomy, School of Medicine, Keimyung University, Daegu 42061, Korea.
Medicina (Kaunas, Lithuania)
|September 16, 2020
Summary
Telomere reverse transcriptase (TERT) expression is crucial for the development of tubular adenomas in colorectal tissue. Targeting TERT and KRAS pathways may offer new strategies for colorectal cancer prevention.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Telomere regulation is linked to colorectal cancer development.
- Previous research indicates telomere dysfunction's role in colorectal carcinogenesis.
- Telomerase reverse transcriptase (TERT) is a key enzyme in telomere maintenance.
Purpose of the Study:
- To investigate the role of TERT in colorectal carcinogenesis.
- To quantify TERT expression in precancerous colorectal lesions.
- To identify associations between TERT expression and specific gene mutations (KRAS, BRAF) and microsatellite instability.
Main Methods:
- Analysis of TERT expression in 93 colorectal precursor lesions (61 tubular adenomas, 32 serrated polyps).
- Detection of KRAS and BRAF gene mutations and microsatellite instability.
- Statistical analysis to determine relationships between TERT expression and clinicopathological variables.
Main Results:
- TERT expression was significantly higher in tubular adenomas compared to paired adjacent non-tumor tissues.
- TERT expression levels were significantly lower in serrated polyps.
- KRAS and BRAF mutations were mutually exclusive; TERT expression showed a non-significant trend towards association with KRAS mutations and low-grade tumors.
Conclusions:
- TERT expression plays a significant role in the progression of tubular adenomas in colorectal tissue.
- The association between TERT expression and KRAS mutation suggests potential therapeutic targets for colorectal cancer prevention.
- Targeting the TERT/KRAS pathway could be a promising strategy for early intervention in colorectal neoplasia.
Related Concept Videos
Renewal of Intestinal Stem Cells
3.0K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.0K
Tumor Progression
7.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.0K

